How are PHG strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PHG strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 29.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$120.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a PHG strangle?

The breakeven for the PHG strangle priced on this page is roughly $22.80 and $28.20 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PHG market-implied 1-standard-deviation expected move is approximately 8.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current PHG implied volatility affect this strangle?

PHG ATM IV is at 29.90% with IV rank near 3.69%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

PHG Strangle Strategy

PHG (Koninklijke Philips N.V.), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB.

PHG (Koninklijke Philips N.V.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $24.40B, a trailing P/E of 21.44, a beta of 0.92 versus the broader market, a 52-week range of 21.95-33.44, average daily share volume of 1.1M, a public-listing history dating back to 1980, approximately 67K full-time employees. These structural characteristics shape how PHG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.92 places PHG roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. PHG pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on PHG?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current PHG snapshot

As of May 15, 2026, spot at $25.24, ATM IV 29.90%, IV rank 3.69%, expected move 8.57%. The strangle on PHG below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this strangle structure on PHG specifically: PHG IV at 29.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a PHG strangle, with a market-implied 1-standard-deviation move of approximately 8.57% (roughly $2.16 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PHG expiries trade a higher absolute premium for lower per-day decay. Position sizing on PHG should anchor to the underlying notional of $25.24 per share and to the trader's directional view on PHG stock.

PHG strangle setup

The PHG strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PHG near $25.24, the first option leg uses a $27.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PHG chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PHG shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$27.00	$0.55
Buy 1	Put	$24.00	$0.65

PHG strangle risk and reward

Net Premium / Debit: -$120.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$120.00
Breakeven(s): $22.80, $28.20
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

PHG strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on PHG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$2,279.00
$5.59	-77.9%	+$1,721.04
$11.17	-55.7%	+$1,163.08
$16.75	-33.6%	+$605.12
$22.33	-11.5%	+$47.16
$27.91	+10.6%	-$29.20
$33.49	+32.7%	+$528.76
$39.07	+54.8%	+$1,086.72
$44.65	+76.9%	+$1,644.68
$50.23	+99.0%	+$2,202.64

When traders use strangle on PHG

Strangles on PHG are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PHG chain.

PHG thesis for this strangle

The market-implied 1-standard-deviation range for PHG extends from approximately $23.08 on the downside to $27.40 on the upside. A PHG long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PHG IV rank near 3.69% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PHG at 29.90%. As a Healthcare name, PHG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PHG-specific events.

PHG strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PHG positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PHG alongside the broader basket even when PHG-specific fundamentals are unchanged. Always rebuild the position from current PHG chain quotes before placing a trade.

Frequently asked questions

What is a strangle on PHG?: A strangle on PHG is the strangle strategy applied to PHG (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PHG stock trading near $25.24, the strikes shown on this page are snapped to the nearest listed PHG chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PHG strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PHG strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 29.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$120.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PHG strangle?: The breakeven for the PHG strangle priced on this page is roughly $22.80 and $28.20 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PHG market-implied 1-standard-deviation expected move is approximately 8.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on PHG?: Strangles on PHG are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PHG chain.
How does current PHG implied volatility affect this strangle?: PHG ATM IV is at 29.90% with IV rank near 3.69%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.